Durable response to osimertinib in an advanced lung adenocarcinoma patient with an uncommon EGFR T854A mutation: A case report

Epidermal growth factor receptor (EGFR) T854A mutation in exon 21 is an uncommon EGFR mutation in patients with non-small cell lung cancer (NSCLC). It is a secondary EGFR mutation after first- and second-generation EGFR tyrosine kinase inhibitors (TKIs). All EGFR T854A mutations were co-occurred wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Nan, Xin, Hua, Qin, Changjuan, Li, Zhiqi, Sun, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750594/
https://www.ncbi.nlm.nih.gov/pubmed/36626541
http://dx.doi.org/10.1097/MD.0000000000031875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750594/
https://www.ncbi.nlm.nih.gov/pubmed/36626541
http://dx.doi.org/10.1097/MD.0000000000031875

Ejemplares similares